Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-β1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers | Zendy

Taylan Turan | Zendy; Meral Torun | Zendy; Funda Atalay | Zendy; Aymelek Gönenç | Zendy

Open Access

Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-β1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers

Author(s) -

Taylan Turan,

Meral Torun,

Funda Atalay,

Aymelek Gönenç

Publication year - 2017

Publication title -

turkish journal of pharmaceutical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.241

H-Index - 14

eISSN - 2148-6247

pISSN - 1304-530X

DOI - 10.4274/tjps.81994

Subject(s) - biomarker , vitronectin , cadherin , epithelial ovarian cancer , predictive value , medicine , endometrial cancer , oncology , cancer research , ovarian cancer , cancer , biology , receptor , cell , integrin , biochemistry , genetics

Extracellular matrix components, including vitronectin (VN), soluble epithelial-cadherin (sE-cadherin) and transforming growth factor-beta 1 (TGF-β1), play a key role in the invasion and metastasis of cancer. The objective of the study was to determine the clinical significance of serum levels of these molecules in patients with endometrial and ovarian cancers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research